hcplive podcasts

Peer Exchange

HCPLive® peer-to-peer panel discussions feature authoritative insights, opinions, and perspectives on important issues facing today's cancer care professionals.

EP. 1: C. Difficile Risk Factors and Manifestation

EP. 2: Strains of C. Difficile

EP. 3: Managing Community-Onset C. Difficile

EP. 4: Recurrent C. Difficile

EP. 5: C. Difficile: A Differential Diagnosis

EP. 6: Testing for C. Difficile Infections

EP. 7: Screening for C. Difficile

EP. 8: C. Difficile: Clinical Practice Guidelines and Treatment Options

EP. 9: C. Difficile: Updates to Clinical Practice Guidelines

EP. 10: Selecting Therapy to Treat C. Difficile.

EP. 11: C. Difficile Treatment: Fidaxomicin

EP. 12: Choosing Between Vancomycin and Fidaxomicin for C. Difficile Infections

EP. 13: C. Difficile Treatment: Bezlotoxumab

EP. 14: Preventing/Treating C. Difficile: Unmet Needs

EP. 15: Fecal Microbiota Transplantation for C. Difficile Infections

EP. 16: Emerging Treatment Options for C. Difficile Infections

EP. 17: C. Difficile: Barriers Treating With FMT

EP. 18: Making Strides in the Management of C. Difficile

EP. 1: Overview of Psoriatic Arthritis

EP. 2: Psoriatic Arthritis: Comorbidities and Quality of Life

EP. 3: Early Diagnosis of Psoriasis and Psoriatic Arthritis

EP. 4: Clinical Manifestations of PsA

EP. 5: Diagnosis of Psoriatic Arthritis

EP. 6: Goals of Therapy in Psoriasis and Psoriatic Arthritis

EP. 7: Nonbiologics: Treatment of PsO and PsA

EP. 8: Management of Psoriatic Arthritis With Biologics

EP. 9: Approaching Treatment of Psoriatic Arthritis

EP. 10: DISCOVER-1/2 Trials in PsA

EP. 11: Safety and Efficacy of IL-23 Inhibitors for Treatment of PsA

EP. 12: Impact of IL-23 Inhibitors on Pain and Fatigue in PsA

EP. 13: Biologics in PsA: Monotherapy vs Combination Therapy

EP. 14: Switching Therapies in PsA

EP. 15: Managing Psoriatic Arthritis During COVID-19

EP. 1: Role of NOACs in Venous Thromboembolism and COMPASS Trial

EP. 2: COMPASS Trial: Subgroup Analysis and Implications

EP. 3: Rationale and Study Design of the VOYAGER PAD Trial

EP. 4: Case 1: Antithrombotic Regimen in High-Risk Patient

EP. 5: Case 1: Choice of Therapy for Peripheral Artery Disease

EP. 6: Case 1: THEMIS Trial and Subgroup Analysis With Revascularization

EP. 7: Case 2: Triple Antiplatelet Therapy in Patients With Stents

EP. 8: Case 2: Combination of Device and Drug for Patients With Stents

EP. 9: Case 2: Relationship Between LDL and Major Adverse CV Events

EP. 1: Overview of Uncontrolled Asthmatic Episode

EP. 2: Quality of Life and Increased Risk of Asthma Exacerbations

EP. 3: Over and Under Diagnosis of Asthma

EP. 4: Targeted Pathology for the Treatment of Asthma

EP. 5: Common Biomarkers of Asthma to Determine Treatment Efficacy

EP. 6: Raising Awareness Among Physicians Regarding Biologics

EP. 7: FDA Approved Agent Omalizumab for Asthma

EP. 8: Patient Factors That Determine the Use of Omalizumab in Asthma

EP. 9: IL-5 Inhibitors for Treatment of Asthma

EP. 10: Dupilumab for Moderate to Severe Asthma

EP. 11: Safety Profile of Biologics When Treating Asthma

EP. 12: Managing Asthma During COVID-19

EP. 13: Precautions Taken to Control Asthma During COVID-19

EP. 14: Anxiety Among Patients With Asthma During COVID-19

EP. 15: Importance of Flu Shots for Patients With Asthma During COVID-19

EP. 1: Pathogenesis of Plaque Psoriasis and Triggering Factors

EP. 2: Clinical Manifestations and Progressive Nature of Psoriasis

EP. 3: Factors That Influence Choice of Treatment for Plaque Psoriasis

EP. 4: Effect of Multiple Sclerosis and Obesity on Treatment of Psoriasis

EP. 5: Medical Benefit of Office Administration of Tildrakizumab

EP. 6: Experience With Using Older Biologics to Treat Psoriasis

EP. 7: Adverse Events of TNF Inhibitors Used to Treat Psoriasis

EP. 8: Contraindications to the Conventional Treatment for Psoriasis

EP. 9: HIV as a Contraindication for Treatment of Psoriasis

EP. 10: Managing Depression as a Psychological Effect of Psoriasis

EP. 11: IL-23 Inhibitors for Treatment of Plaque Psoriasis

EP. 12: Case Study of a 23-Year-Old Female With Plaque Psoriasis

EP. 13: 49-Year-Old Female With Psoriasis and Latent Tuberculosis

EP. 14: Elderly Male With Plaque Psoriasis, Metabolic Syndrome

EP. 15: Challenges in Treating Patients With Plaque Psoriasis

EP. 16: Unmet Needs and Emerging Treatments for Psoriasis

EP. 1: Guidelines to Manage Blood Cholesterol

EP. 2: Targeting LDL Cholesterol

EP. 3: Coronary Calcium Scoring to Assess Cardiovascular Risk

EP. 4: Disparities in Lipid Management

EP. 5: Statin Therapy Selection and Shared Decision-Making

EP. 6: Management of Statin Intolerance/Myalgias

EP. 7: Ezetimibe to Help Lower LDL-C

EP. 8: Bempedoic Acid to Reduce LDL-C

EP. 9: Icosapent Ethyl for Cardiovascular Risk

EP. 10: PCSK9 Inhibitors to Help Lower LDL-C

EP. 11: LDL-C Lowering Therapy Under Study: Inclisiran

EP. 12: LDL-C Lowering: Adopting Inclisiran Into Practice

EP. 13: Paradigm Shift in Lipid Management: Series Takeaways

x